Drugs / AZD5423
Trials 7 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 15 trials | ||||||
| Phase 1 | NCT01635985 | Aug → Dec 2012 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT01338350 | Jun → Dec 2011 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT01310322 | Apr → Oct 2011 | asthma | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT01037504 | Jan → Apr 2010 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 1 | NCT00963183 | Aug → Nov 2009 | — | AstraZeneca | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT01555099 | Apr 2012 → Apr 2013 | chronic obstructive pulmonary disease | AstraZeneca | Completed | No outcome recorded |
| Phase 2 | NCT01225549 | Nov 2010 → Dec 2011 | asthma | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AZD5423 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01555099 ↗ |
| Action | Activate | “nonsteroidal glucocorticoid receptor agonist AZD5423” PMID 25473939 ↗ Jan 2015 |
| Modality | Other / unclassified | “inhaled nonsteroidal glucocorticoid receptor agonist, AZD5423” PMID 25473939 ↗ Jan 2015 |
| Route | Inhaled | “Solution for nebulisation, inhaled.” NCT00963183 ↗ |
| Target | NR3C1 | “Glucocorticoid receptor modulator” CHEMBL4072756 ↗ |